Contact: Mika Ono
Scripps Research Institute
Caption: The researchers demonstrated their new technique by engineering a compound that has promise to initiate an otherwise rare immune response against many types of HIV. Here, the germline-targeting immunogen eOD-GT6 (red) is shown bound to its target, the germline VRC01 antibody (magenta and yellow).
Credit: Photo courtesy of The Scripps Research Institute.
Usage Restrictions: None
Related news release: New vaccine-design approach targets HIV and other fast-mutating viruses